Pharmacology and clinical use of the new ACE-inhibitor moexipril

被引：22
|
作者：
Stimpel, M
Bonn, R
Koch, B
Dickstein, K
机构：
[1] SCHWARZ PHARMA AG, DEPT HUMAN PHARMACOL, D-40789 MONHEIM, GERMANY
[2] CENT HOSP STAVANGER, DIV CARDIOL, STAVANGER, NORWAY
来源：
CARDIOVASCULAR DRUG REVIEWS | 1995年 / 13卷 / 03期
关键词：
moexipril; ACE inhibition; antihypertensive drugs;
D O I：
10.1111/j.1527-3466.1995.tb00304.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：211 / 229
页数：19
相关论文
共 50 条
  • [31] Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients
    Kantola, I
    Terent, A
    Honkanen, T
    Jarvelainen, V
    Ekman, K
    Kataja, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 50 (03) : 155 - 159
  • [32] THE ENDOTHELIUM AND VASCULAR EFFECTS OF THE ACE-INHIBITOR TRANDOLAPRILAT
    VIDAL, M
    JOLY, G
    MOMBOULI, JV
    BOULANGER, CM
    VANHOUTTE, PM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 : S1 - S5
  • [33] Antihypertensive efficacy of the ACE-inhibitor perindopril in the elderly
    Leenen, FHH
    Tanner, J
    McNally, CF
    JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (05) : 321 - 325
  • [34] ACE-inhibitor cough in the Australian pink galah
    Watts, RW
    MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (11-12) : 682 - 682
  • [35] PHARMACOKINETICS, PHARMACODYNAMICS AND BIOAVAILABILITY OF THE ACE-INHIBITOR RAMIPRIL
    VANGRIENSVEN, JMT
    SCHOEMAKER, RC
    COHEN, AF
    LUUS, HG
    SEIBERTGRAFE, M
    ROTHIG, HJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 47 (06) : 513 - 518
  • [36] Antihypertensive efficacy of the ACE-inhibitor perindopril in the elderly
    FHH Leenen
    J Tanner
    CF McNally
    Journal of Human Hypertension, 2000, 14 : 321 - 325
  • [37] Small Bowel Angioedema Secondary to ACE-Inhibitor
    Frankel, Jennifer
    Brown, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S260 - S261
  • [38] Long-term ACE-inhibitor therapy
    Brophy, JM
    Joseph, L
    LANCET, 2000, 356 (9226): : 338 - 338
  • [39] MUSCULAR DYSTROPHY PATIENTS WITH SEVERE RENAL DYSFUNCTION: ANALYSIS OF ACE-INHIBITOR USE
    Vlahiotis, A.
    Stott-Miller, M.
    Palmer, L. A.
    VALUE IN HEALTH, 2015, 18 (07) : A763 - A763
  • [40] ACE-inhibitor use and the long-term risk of renal failure in diabetes
    Suissa, S
    Hutchinson, T
    Brophy, JM
    Kezouh, A
    KIDNEY INTERNATIONAL, 2006, 69 (05) : 913 - 919
12345